Industry analysis pharma


Published on

1 Comment
  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide
  • Indian Drug Manufacturers' Association (IDMA)
    OPPI - Organisation of Pharmaceutical Producers of India
    Bulk Drug Manufacturers Association
    Association of Pharmaceutical Teachers of India
    Indian Pharmaceutical Association
    Confederation of Indian Pharmaceutical Industry (SSI)
  • Industry analysis pharma

    1. 1. Industry Analysis: Pharma Presented By:- Neeraj Goswami Prerna Agarwal Ojaswi Katiyar “The Indian pharmaceutical industry is a success story providing employment for millions and ensuring that essential drugs at affordable prices are available to the vast population of this sub- continent.” Richard Gerster
    2. 2. Contents 1) Overview of Indian pharma. 2) Evolution of Indian Pharma. 3) Major players. 4) Drug Trial. 5) Medical tourism. 6) Moving up to the value chain. 7) Pharmaceutical-association in India. 8) Future scenario. 9) Pharma in news.
    3. 3. Indian Pharmaceutical Evolution Phase II Government Control •Indian Patent Act – 1970 •Drug prices capped •Local companies begin to make an impact Phase III Development Phase •Process development •Production infrastructure creation •Export initiatives Phase IV Growth Phase •Rapid expansion of domestic market •International market development •Research orientation Phase V Innovation and Research •New IP law •Discovery Research •Convergence 1970 1980 1990 2000 2010 Phase I Early Years •Market share domination by foreign companies •Relative absence of organized Indian companies
    4. 4. Drug Trial • Phase-1 • Phase-2 • Phase-3 • Phase-4 Benefits:- • Play an active role in their own health care. • Gain access to new research treatments before they are widely available. • Obtain expert medical care at leading health care facilities during the trial. • Help others by contributing to medical research. Risks:- • There may be unpleasant, serious or even life-threatening side effects to experimental treatment. • The experimental treatment may not be effective for the participant.
    5. 5. Medical Tourism • Cheaper medical and relaxation needs. • Excellent infrastructure and technology in which is in par with those in USA, UK and Europe. • Some treatments which are best in India are:- Eye Care Dental Care IVF Treatment Heart Surgery & Heart Care Health Check Up Cosmetic Treatment Orthopedic Surgery
    6. 6. Moving up the Value Chain Specialty Products Innovative Products TIME Generic exports to under- developed & developing countries Generic exports to developed countries API Exports VALUE
    7. 7. Pharmaceutical Associations In IndiaIDMA CIPI-SSI OPPI IPA BDMA APTI
    8. 8. Indian Pharma Industry – Future Scenario • The Indian pharma industry is still trying to come to terms with the new patent regime. • Over the next 5 years, will continue to grow by at least twice the rate of global growth. • Retail segment will be the fastest growing segment. • There will be a significant increase in the clinical trials and diagnostics outsourcing. • A significant window of opportunity will be available expiring patents.
    9. 9. Pharma in News • August 20, 2008: 49 babies die at leading hospitals under drug trail process. • Fight between Ranbaxy and Pfizer.(Lipitor) • H1N1 vaccination available in Indian Pharmaceutical market. (Nasovac) • Aurobindo pharma and Astra-Zeneca to jointly supply solid dosage in emerging market.
    10. 10. Biblograpahy • • • • • www.pharmaceutical-drug- •